ToMORROW (Cephapirin Benzathine) Dry Cow Mastitis Treatment

Boehringer Ingelheim

11128

As low as

$32.76

Total Items: 0

Select item(s) below before adding to cart.

Time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows

Formulated with cephapirin benzathine and shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus ...Read More

  • Qty
    Price Each
  • ToMORROW (Cephapirin Benzathine) Dry Cow Mastitis Treatment -
    Box/12
    item #: 11128-1
    Warning This item cannot ship to CA addresses
    We honor Boehringer Ingelheim Contract Pricing on this item. More info
    Buy in Quantity of 12 for a Case
    Available in cases, when you
    buy in quantities of 12
    11128-1
    Check Ready to Ship
    $32.76
  • ToMORROW (Cephapirin Benzathine) Dry Cow Mastitis Treatment -
    Pail/144
    item #: 11128-2
    Warning This item cannot ship to CA addresses
    We honor Boehringer Ingelheim Contract Pricing on this item. More info
    Buy in Quantity of 1 for a Case
    Available in cases, when you
    buy in quantities of 1
    11128-2
    Check Ready to Ship
    $376.83

Product Features

  • Herd Health Pays Producer Program rebate form link below
  • A healthier dry period means better milk. Period.
  • For intramammary infusion into the dry cow
  • Provides a great return on investment and reduces the risk of new infections
  • "Parlor Pails" offer convenient, efficient mastitis treatment for the large dairy farm
Ships Today!
Order before 4PM ET Monday-Friday

Description

Formulated with cephapirin benzathine and shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus including penicillin-resistant strains.

TOMORROW has been an effective extended therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.1,2

Formulated to provide broad-spectrum and long-acting therapy that dry cows need. 

  • Unique Opti-Sert® tip helps prevent pushing harmful surface bacteria into the teat canal 
  • Reduces the risk of new infections 
  • Allows antibiotic contact with teat-canal infections 
  • Provides the option of partial or full insertion with an exclusive, easy-to-use protective cap.
Top reasons to use ToMORROW: 
  1. A recent head-to-head study conducted on six dairy farms in four states shows less than 5 percent of all dry cow mastitis pathogens at dry-off were Gram-negative.1
  2. First-generation cephalosporins continue to maintain high effectiveness against Gram-positive organisms, and are more effective against those pathogens than third-generation cephalosporins.2,3
  3. Head-to-head study showed no difference in efficacy between the leading dry cow mastitis tubes.1
  4. Authors of the study concluded that "due to the lack of difference in efficacy, other factors should be used in the consideration of dry cow mastitis treatment, including prudent use of antibiotics, withhold times and value."1
  5. ToMORROW provides superior value.
Box contains 12 x 10 ml syringes with 12 convenient single use alcohol pads. Pail contains 144 x 10 ml syringes and 144 convenient single use alcohol pads.

Dosage Information:
Infuse a 10 ml syringe (300 mg cephapirin activity per syringe) once each quarter has been completely milked out. Effective against both gram-positive and gram-negative bacteria, especially Strept agalactiae and Staph aureus.

72 hour milk withholding; 42 day slaughter withdrawal. Not to be used within 30 days of calving.

Proper Infusion Technique


1 Arruda AG, Godden S, Rapnicki P, et al. Randomized non-inferiority clinical trial evaluating three commercial dry cow mastitis preparations: I. Quarter-level outcomes. J Dairy Sci 2013;96(7):4419–4435.
2 Prescott JF. Antimicrobial chemotherapy. In: Hirsh DC, Maclachlan NJ, Walker RL, eds. Veterinary microbiology. 2nd ed. Ames: Iowa State University Press, 2004;30.
3 Pol M, Ruegg PL. Relationship between antimicrobial drug usage and antimicrobial susceptibility of Gram-positive mastitis pathogens. J Dairy Sci 2007;90(1):262–273.


Rebate Form: Herd Health Pays Producer Program (through October 31, 2018)


View Manufacturer and/or Label Information: 

Helpful Information

Our helpful, friendly and knowledgeable Animal Health Product Experts are ready to serve you, simply...
Email email@pbsanimalhealth.com or call 800-321-0235 to help answer any questions or help you find what you need. We look forward to hearing from you!

We honor Boehringer Ingelheim Contract Pricing on this item. Please Log In to see your Boehringer Ingelheim Contract Pricing on file with us for your account. If your price does not reflect Boehringer Ingelheim Contract Pricing or if you have any questions, please contact us at email@pbsanimalhealth.com or 800-321-0235, so we can address it promptly. Your satisfaction is Priority #1!

Reviews

0
There are no reviews for this product yet, be the first to write a review!

Top of Page